Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evoke Pharma

3.14
-0.0900-2.79%
Post-market: 3.140.00000.00%16:00 EDT
Volume:11.63K
Turnover:37.30K
Market Cap:4.69M
PE:-1.12
High:3.27
Open:3.24
Low:3.13
Close:3.23
Loading ...
Feb 08, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 07, 2024

Correspondence

Form CORRESP - Correspondence
Feb 07, 2024

Correspondence

Form CORRESP - Correspondence
Jan 17, 2024

Correspondence

Form CORRESP - Correspondence
Jan 17, 2024

Correspondence

Form CORRESP - Correspondence
Jan 16, 2024

Correspondence

Form CORRESP - Correspondence
Jan 16, 2024

Correspondence

Form CORRESP - Correspondence
Jan 11, 2024

Correspondence

Form CORRESP - Correspondence
Jan 11, 2024

Correspondence

Form CORRESP - Correspondence
Jan 11, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 05, 2024

Correspondence

Form CORRESP - Correspondence
Jan 05, 2024

Correspondence

Form CORRESP - Correspondence
Jan 04, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Dec 19, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Dec 15, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 29, 2023

Major Issues Report

Form 8-K - Current report
Nov 27, 2023

Major Issues Report

Form 8-K - Current report
Nov 22, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]